TEMOZOLOMIDE , IRINOTECAN
Phase 2 small_molecule active
Quick answer
TEMOZOLOMIDE , IRINOTECAN for Stage II (pT4)/III colorectal cancer with positive circulating tumor DNA (ctDNA) after oxaliplatin-based adjuvant chemotherapy is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fondazione Telethon ETS
- Indication
- Stage II (pT4)/III colorectal cancer with positive circulating tumor DNA (ctDNA) after oxaliplatin-based adjuvant chemotherapy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active